Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer ; day:1 ; month:6 ; year:2016 ; pages:1-8
European journal of nuclear medicine and molecular imaging ; (1.6.2016), 1-8
- Urheber
-
Zegers, Catharina M. L.
- Beteiligte Personen und Organisationen
-
Hoebers, Frank J. P.
Elmpt, Wouter van
Bons, Judith A.
Öllers, Michel C.
Troost, Esther G. C.
Eekers, Daniëlle
Balmaekers, Leo
Arts-Pechtold, Marlies
Mottaghy, Felix M.
Lambin, Philippe
SpringerLink (Online service)
- DOI
-
10.1007/s00259-016-3429-y
- URN
-
urn:nbn:de:1111-2016060236053
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zegers, Catharina M. L.
- Hoebers, Frank J. P.
- Elmpt, Wouter van
- Bons, Judith A.
- Öllers, Michel C.
- Troost, Esther G. C.
- Eekers, Daniëlle
- Balmaekers, Leo
- Arts-Pechtold, Marlies
- Mottaghy, Felix M.
- Lambin, Philippe
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer](/assets/placeholder/searchResultMediaUnknown.png)
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol